Hypoxia and hyperoxia,
referring to states of biological tissues
in which oxygen supply is in sufficient and excessive, respectively,
are often pathological conditions. Many luminescent oxygen probes
have been developed for imaging intracellular and in vivo hypoxia, but their sensitivity toward hyperoxia becomes very low.
Here we report a series of iridium(III) complexes in which limited
internal conversion between two excited states results in dual phosphorescence
from two different excited states upon excitation at a single wavelength.
Structural manipulation of the complexes allows rational tuning of
the dual-phosphorescence properties and the spectral profile response
of the complexes toward oxygen. By manipulating the efficiency of
internal conversion between the two emissive states, we obtained a
complex exhibiting naked-eye distinguishable green, orange, and red
emission in aqueous buffer solution under an atmosphere of N2, air, and O2, respectively. This complex is used for
intracellular and in vivo oxygen sensing not only
in the hypoxic region but also in normoxic and hyperoxic intervals.
To the best of our knowledge, this is the first example of using a
molecular probe for simultaneous bioimaging of hypoxia and hyperoxia.
Transition metal complexes containing pyrazinium or pyridinium moieties display reversible luminescence changes in response to electrical stimuli, which is useful in the development of erasable information recording electric devices. These complexes are also suitable for temperature-related information protection, since chemically-induced luminescence turn-on is temperature-dependent.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.